Nxera Pharma, formerly Sosei Group, rebrands, focusing on accelerating life-changing medicine development.

Nxera Pharma, previously known as Sosei Group, has rebranded, reflecting its focus on accelerating life-changing medicine development through science and technology. The rebranding includes subsidiaries Heptares Therapeutics and Idorsia Pharmaceuticals Japan and Korea. CEO Chris Cargill stated that the name change marks a pivotal moment, following significant growth and strategic acquisitions.